Okuma, Hitomi S

Trends in the development of MET inhibitors for hepatocellular carcinoma. [electronic resource] - Future oncology (London, England) May 2016 - 1275-86 p. digital

Publication Type: Journal Article; Review

1744-8301

10.2217/fon.16.3 doi


Antineoplastic Agents--therapeutic use
Carcinoma, Hepatocellular--drug therapy
Humans
Liver Neoplasms--drug therapy
Molecular Targeted Therapy
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Proteins c-met--antagonists & inhibitors